Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
How many of us have medicine cabinets where we store our “you never know” items?
While high costs and other challenges remain a concern, specialty drugs including biologics and biosimilars should be continually evaluated for pot
Company continues to add to its growing portfolio of issued U.S.
Latest achievement driven by increasing vehicle complexity and growing reliance on the company's ADAS calibration target system